by adminAdrianRamirez | Mar 28, 2017 | Axim Biotechnologies, Press Releases
[vc_row][vc_column][vc_column_text]SAN DIEGO, March 28, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech)...
by adminAdrianRamirez | Mar 27, 2017 | Kannaway, Press Releases
SAN DIEGO, March 27, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has unveiled a renewed line of chewable energy products meant...
by adminAdrianRamirez | Mar 23, 2017 | Axim Biotechnologies, Press Releases, Scientific Research
In order to fast-track approval of its new products, AXIM® Biotechnologies, Inc., a Medical Marijuana, Inc. investment company, has retained the services of Ora®, Inc. for the development of its cannabinoid-based eye treatments. A global Contract Research...
by adminAdrianRamirez | Mar 21, 2017 | Axim Biotechnologies, Press Releases
NEW YORK, March 21, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM®Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in...
by adminAdrianRamirez | Mar 16, 2017 | Kannaway, Press Releases
SAN DIEGO, March 16, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products is holding an exclusive Red-Carpet Event in Denver, CO., this...
by adminAdrianRamirez | Mar 14, 2017 | HempMeds Mexico, Press Releases, Scientific Research
The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these...